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Abstract
The immune system is influenced by vitamin B complex: B1, B2, B3, B5, B6, 
B7, B9 and B12. The B complex insufficiency can cause significant impairment 
in cellular and immune function and trigger an inflammatory response. There is 
currently no certified SARS-CoV-2 treatment or a credible vaccine, but strengthen-
ing the immune system with B vitamins could go a long way in preventing and 
treating COVID-19 patients. Thus, a complete and nutritious diet must be followed 
before approved drugs and potential good vaccine research results are available to 
boost the normal functioning of the immune system. In order to activate adaptive 
and inborn immune responses, reduce cytokine levels such as proinflammatory 
cytokines, decrease oxidative stress, preserve endothelial homogeneity, improv-
ing pulmonary function, prevents hypercoagulable conditions and shortening the 
length of hospital stay; B-Complex vitamins play a significant role. Thus, the role of 
B complex in patients with COVID-19 needs to be evaluated and additional non-
drug B vitamins can be used in existing treatments.
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1. Introduction
The severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 virus is 
the cause of COVID-19. The World Health Organisation reported that COVID19 
became an international global health crisis in January 2020 and that COVID19 has 
become a global epidemic, causing more than 20 million infections and 7 million 
deaths by March 2020. COVID-19 clinical signs include arthromyalgia, cough, 
diarrhoea, fevers, headache, lethargy, multiorgan disorder, severe interstitial 
pneumonia and septic coagulomas [1]. The severe development of COVID-19 also 
leads to a cytokine storm and excessively pro-inflammatory cytokine secretion [2]. 
In 2002–2004 and 2012–2014, epidemics of similar β-caronaviral virus (SARS) and 
Middle East Respiratory Syndrome (MERS), have previously taken place [3, 4].
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2.  Food supplements to improve immune quality, antioxidants and 
anti-inflammation
Today, most states all around globe are working to develop corona vaccines, with 
a number entering human studies while most of them are being studied and devel-
oped in various stages. Furthermore, there are no specialised COVID-19 drugs, 
nor are there any meaningful statistics on the impacts of nutritional additives on 
COVID-19 risk or seriousness at both national and international levels. Developing 
new antiviral medications for COVID-19 is a major challenge that requires signifi-
cant time and resources in the development and evaluation of this product. Several 
scores of proof signify, in particular in people with insufficient food resources as 
well as through their free radical scavenging, anti-inflammatory or viricidal capa-
bilities, that many supplements from various vegetables, fruits, spices, herbs and 
root sources can decrease the hazard or intensity of a diverse variety of viral infec-
tions. These nutrients may be recycled to reduce the disease effects of SARS-CoV-2 
infection. Thus the utilisation of natural compounds, together with the treatment 
for COVID-19, can propose new preventative and treatment support. The positive 
effects of certain nutrients are discussed in the following section [5].
3. Vitamin B and its biological roles
Vitamin B complex are the main vitamin of the brain function, eyes, gastroin-
testinal tract, liver, hair, muscular tone, nervous system, skin, and are critical to 
the health of the nervous system. These vitamins next to each other help to detoxify 
the organ, promote good metabolism, release enzymes from the food, stabilise the 
functions of your nervous system, provide cells with plenty of oxygen, maintain 
healthy skin and hair, protect faulty vision and have also been utilised in weaknesses 
[6]. Table 1 provides an overview of the vitamin B complex with its cellular roles, 
scientific name, recommended male and female dose.
4. Vitamin B and pandemic
Due to anti-inflammatory and immunomodulatory properties of vitamin C and 
vitamin D in this era of pandemic they are getting much attention. Low vitamin D 
and C levels lead to coagulopathy and suppression of the immune system causing 
lymphocytopenia. The data showed that in corona virus patients with low levels of 
vitamin D have high mortality rate. In corona virus patients, the consumption of 
vitamin C increases the oxygenation index [9]. Accordingly, a lack of vitamin B can 
seriously alter the function of a cell and immune system that leads to hyperhomo-
cysteinemia inflammation. Vitamin B must be stressed because it plays a key role 
in proper immune function, energy metabolism and cell function [10]. Vitamin B 
helps to reduce inflammation, strengthens respiratory functioning, preserves endo-
thelial homogenity, inhibits hypercoagulation, activate innate and adaptive immune 
responses properly, and can decrease hospitalisation for long periods of time [11]. 
Thus, the role of B complex in patients with COVID-19 needs to be evaluated and 
additional non-drug B vitamins can be used in existing treatments.
5. Food supplements to counteract COVID-19
Phase 1 is critical from the point of view of prevention because individuals are 







































Vitamin Scientific name Coenzymes Groups 
transferred
For women daily 
recommended dose




B1 Thiamine Thiamin pyrophosphate (TPP) Aldehydes 1.1 mg 1.2 mg Energy releasing, tissue 
growth
B2 Riboflavin Flavin Mononucleotide (FMN) H Atoms 1.1 mg 1.3 mg Energy releasing, 
nucleotide synthesis
B3 Niacin Nicotinamide Adenine (NAD+), 
Nicotinamide adenine dinucleotide 
phosphate (NADP+)
H atoms 14 mg 16 mg Energy releasing, lipid 
breakdown and synthesis
B5 Pantothenic acid Coenzyme A (CoA) Acyl groups 5 mg 5 mg Energy production from 
food stuff
Synthesis of fatty acids
B6 Pyridoxine Pyridoxal-5-phosphate (PLP), pyridoxine-
5-phosphate (PNP), pyridoxamine-5′-
phosphate (PMP)
Amino groups 1.3 mg 1.3 mg Amino acid and glycogen 
breakdown
B7 Biotin Biotin CO2 30 μg 30 μg Fatty acid, glucose and 
leucine synthesis
B9 Folic acid Tetrahydrofolate (THF) One carbon group 
except CO2




methylcobalamine Methyl groups, 
hydrogen atoms
2.4 μg 2.4 μg Amino acid metabolism
Nucleotide synthesis
Breakdown of fatty acids
Folic acid regeneration
Table 1. 
Summary of Vitamin B complex [7, 8].
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mounting of specific adaptive immune responses in persons and the utilisation of 
antivirals in phase 1 is vital for preventing entry of virus, disease progression and 
replication to phase 2. Global strategies can thus include administering external 
antivirals and food supplements that increase immune levels. In addition to retain-
ing the overall status of the patient, phase 2 of the infection can be adapted for 
treatment to protect damage and malfunction to tissue in the course of the treat-
ment by using nutritional supplements that can repress continuing oxidative stress, 
acute inflammation and cytokine storms. In short, in order to improve the immune 
response in phase one and eliminating it in the second phase, approaches to counter 
SARS-CoV-2 are effective, in addition to symptomatic treatment [5, 12].
6. Pathogenesis of COVID-19
The information provided shows that infection pathogenesis can be divided 
into two components. Phase 1: an asymptomatic phase of detectable viruses or not. 
Phase 2: High viral load symptomatic phase [13]. After binding the S protein into 
the ACE2 receptors and then initiating cellular transmembrane protease, serine 2 
(TMPRSS2) and then the virus enters the airway epithelium. After the virus enters 
the host, innate interferon (IFN) immune response will be inhibited or delayed 
[14]. Ubiquitation and breakdown of RNA sensor molecules interrupts with down-
stream signalling [5, 15]. After an impairment of the IFN viral replication system, 
activation is generated of the granulocytes macrophages and monocytes that lead to 
the description of the “cytokine storm.” The activation of proinflammatory cyto-
kines, which involves interleukin IL-12, IL-8, IL-6 and IL-1 are described, involves 
massive secretions of the tumour necrosis factor (TNF-α). Tissue fibrosis, pneu-
monia and hyperinflammation of tissues is associated with this [16]. Research has 
suggested that oxidative stress is involved in COVID-19 pathogenesis. The evidence 
seems to indicate that SARS-CoV-2 actually causes oxidative stress by improving 
reactive oxygen species (ROS) production and indirectly suppressing host defence 
[17]. Moreover, granulocytosis also contributes to superoxide ions, a kind of of ROS 
Figure 1. 
Schematic representation of pathogenesis of COVID-19. Phase 1 which is asymptomatic includes dysregulation 
of host innate immune system, elevation of oxidative stress and phase 2 is acute inflammatory harmful phase 
[12, 24].
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and an extra development of proinflammatory cytokines in response to SARSCoV-2 
infections [16, 18, 19]. High levels of cytokines also cause HA-synthase-2 (HAS2) 
endothelial inductions in alveolar and fibroblast epithelial cell (Type 2) [20–23]. 
Lungs of patients with corona virus have increased cytokine (IL-1, TNF-α) inflam-
matory levels. This is related to higher HAS2 activity and successive corona virus 
lung pathophysiology. The clinical and scientific study results above therefore 
recommend that corona virus pathogenesis consists of two stages: Stage 1, dysregu-
lation of host innate immune system, elevation of oxidative stress and phase 2 is 
acute inflammatory harmful phase (Figure 1).
7.  Cross-discussion of immunity, inflammation and oxidative stress with 
vitamin B complex
In 1936 R.R. Williams and his coworkers defined their chemical structure and 
were able to synthesise the Vitamin B1 (thiamin) as the oldest vitamin. Vitamin B1 
has an impact on anti-inflammatory characteristics, cytochrome C release, mito-
chondrial membranes, oxidative stress-induced, NF-kappaβ and protein kinases, 
P38-MAPK. Over expression of proinflammation cytokines like TNF, IL-1, IL-6, and 
arachidonic acid products, nervous system malfunction, T-cycle infiltration, neu-
roinflammation, expression CD40 by the microglia and CD40L, causing the loss of 
astrocytes, beriberi, CL2 chemokine over expression all are the outcomes of deficient 
vitamin B1 [25].
Therapies with vitamin B complex reduced proinflammatory expression and 
enhanced anti - proliferative cytokine activity, thereby making a contribution to 
neuroinflammatory resolution. Macrophages are usually grouped into two major 
subtypes: (i) macrophages (M1) that are involved as principal phagocytic cells in 
the inflammatory sites; and (ii) macrophages (M2) which carry out the process of 
tissue reshaping following inflammatory cellular activity. At the same time, B vita-
mins reduced the macrophage count for M1 and improved the macrophage count 
of M2. Thus, B vitamins have the potency for neuroinflammatory and neuroregen-
erational treatments and could be an excellent remedy for human peripheral nerve 
injury (PNI) [26].
Vitamin B-6 played an important role during the last decades in the mechanism 
for inflammatory and antioxidant activities [27]. PLP may interact with peroxy 
radicals and sequester free radicals and, through its group of hydroxyls, prevent 
lipid peroxidation on the pyridine ring [28]. PLP plays the role as a coenzyme in 
the manufacturing, throughout inflammation, of cytokines as well as other mul-
tipeptide intermediaries [29]. Therefore insufficient vitamin B-6 may diminish its 
antioxidant potential directly or interfere with inflammatory reactions [30].
8. COVID-19 patients: thiamine in hypoxia
Thiamine inadequacy impairs inflammatory profile through neuroinflamma-
tion by affecting cardiovascular system [31]. As the corona virus needs antibodies, 
mainly T cells, thiamine deficiencies can result in insufficient antibody responses 
and consequently in more serious symptoms. Thus, the correct immune responses to 
corona virus infection are effective to assist with sufficient thiamine levels. Moreover, 
COVID-19 symptoms seem to be much related to the disease of altitude and pul-
monary edema of high altitude. By inhibiting carbonic anhydrase enzymes and 
consequently increasing oxygen level, for prevention of high altitude sickness and 
pulmonary edema acetazolamide is commonly prescribed. Thiamine also works as 
B-Complex Vitamins - Sources, Intakes and Novel Applications
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an inhibitor of the carbon anhydrase enzyme, hence the potential of hypoxia limita-
tion and lowered hospitalisation at high concentrations of thiamine administered in 
early COVID-19 people. Research is still needed on the possibility of helping to heal 
COVID-19 patients by administering of increased thiamine doses [11].
9. Riboflavin-UV for inhibition of COVID-19 replication
Riboflavin with UV light is responsible for irreparable destruction to nucleic 
acids such as RNA and DNA, which makes it impossible to replicate microbial 
pathogens. The effectiveness of Riboflavin and UV light against MERS-CoV was 
demonstrated and it may also be of assistance with SARS-CoV-2 [32]. In fact, 
riboflavin-UV reduced the SARS-CoV-2 infective titre below the human blood and 
plasma and platelet identification limit [33]. It may ameliorate the risk of COVID-19 
transfusion and reduce other pathogenic organisms in blood products in patients 
critically ill with COVID-19.
10.  Vitamin B3 (Nicotinamide, Niacin) for blocking cytokine storm in 
inflammation
Niacin is a component of NAD and NADP, which are both essential during 
chronic systemic inflammatory responses. [34]. NAD+ works as a coenzyme in a 
broad variety of metabolic pathologies, and its elevated concentrations are crucial 
for dealing with a range of scenarios. NAD+ has immunomodulatory effects that 
are proven to affect proinflammatory cytokines throughout initial inflammatory 
periods [35, 36]. Current proof shows that IL-6 can regulate inflammatory storm 
in COVID-19 patients [37]. Niacin also decreases neutrophil infiltration and has an 
anti-inflammatory impact in ventilator-induced patients. Nicotinamide and niacin 
in hamsters minimise injury to the lung tissue [38]. Nicotinamide also minimises 
replication of virus and reinforces body mechanisms of protection. It can be used 
as an additional treatment for COVID-19 patients with a view to the lung protective 
and immune bolstering role of niacin [39].
11. Vitamin B5 (pantothenic acid) as anti-inflammatory agent
Vitamin B5 has a variety of functions, such as lipids and triacylglycerols reduc-
tion, improve wounds recovery, reduces inflammation, and enhances mental health 
[10]. Although there is scarce research which shows vitamin B5’s effects on the 
immune system, it is a feasible vitamin for scientific investigations.
12.  PLP supplementation as immunodulatory and anti-inflammatory 
agent
Pyridoxal 5′ phosphate (PLP) is an active component of pyridoxine and is 
a cofactor vital for several inflammatory disorder processes that contribute to 
immune disorder. In chronic inflammatory diseases, PLP has a reverse relation with 
plasma TNF-α and IL-6. Throughout inflammation, PLP use enhances its depletion, 
which means that COVID-19 can be deficient in patients with high inflammatory 
response. In patients with type-2 diabetes and cardiovascular disorder, groups at 
greater risk for relatively poor COVID-19 outcomes were reported with low levels 
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of PLP [40, 41]. Elevated incidence of coagulopathy between many COVID-19 
patients was also observed as a result of immune disregulation. In a recent manu-
script, PLP intake was associated to ameliorate COVID-19 symptoms by regulate 
immune functions, lower pro-inflammatory cytokines, preserve endothelial stabil-
ity and avoid hypercoagulability [42]. Indeed, it was found 30 years ago that platelet 
accumulation and blood coagulation defects were reduced by PLP amounts [43]. 
Vitamin B6 (along with B2 and B9) prediculated IL 10, a potent anti-inflammatory 
and immune suppressant cytokine which can disable monocytes and prevent T cells 
as well as cells present with the antigen [44]. Patients with COVID-19 often fre-
quently react to the virus by implementing a pro-inflammatory T cell response and 
secretion. PLP may help dampen the cytokine storm and inflammatory processes 
suffered by a few patients with COVID-19.
13. Vitamin B9 (folic acid, folate) as furin inhibitor
For DNA, synthesis of protein and adaptive immune reaction, folate seems to 
be essential vitamin. Furin is a bacterial and viral infections-related enzyme and 
a good potential goal for infection treatment. Folic acid has recently been noted 
for being capable of inhibiting furin by avoiding binding of the spike protein 
SARS-CoV-2 and trying to prevent cell input and virus retention. Follic acid was 
thus recommended to be helpful for COVID-19-associated early phase respiratory 
disease management [44]. A latest publication shows the strength and stability of 
folic acid and its derivatives tetrahydrofolic acid and 5 methyl tetrahydrofolic acid, 
via structure-based molecular docking, in connection with SARS-CoV-2. Follic acid 
can thus be used as a treatment strategy for COVID-19 management [45].
14. Vitamin B12 (cobalmin) as antioxidant and gut modulatory agent
For the synthesis of erythrocytes, safety of the nervous system, myelin produc-
tion, angiogenesis and rapid production of DNA, vitamin B12 is critical. Adenosyl-, 
h ydroxo- and methyl cobalamin are active forms of vitamin B12. As modulator for 
intestinal flora and low B12 concentrations, vitamin B12 increases homocysteine 
Figure 2. 
Summary of Vitamin B complex as anti-COVID-19 agent for inhibition of viral replication, viral binding and 
invasion, cytokine storm and hypercoagulabity [9].
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and methyl malonic acid, leading to increasing inflammatory process, ROS and 
oxidative stress [35]. Reduced immune response, endothelial dysfunction, myelin 
sheathing integrity interruption, megaloblastic anaemia, platelets and coagulation 
activation and are caused by hyperhomocysteinemia [46–48]. SARS-CoV-2 may 
perhaps interact with the metabolic activities of vitamin B12 which may affect 
microbiological bowel propagation. Provided that symptoms such as vasoconstric-
tion, increased oxidative stress, cascade-activation of clotting, lactate dehydro-
genase, renal and pulmonary vascular disorder and hyperhomocysteinemia are 
feasible [47, 49]. Furthermore, B12 insufficiency can lead to CNS, gastrointestinal 
and respiratory and abnormalities [48]. Remarkably, a new study shows that 
additional methylcobalamine may minimise damage to the organs and symptoms 
associated with COVID 19 [50]. A Singapore diagnostic research demonstrates that 
the intensity of COVID-19 in patients receiving magnesium, vitamin D (1000 IU) 
and vitamin B12 supplements (500 μg), reduced considerably the need for COVID-
19 symptoms [51]. Figure 2 shows a summary of the anti-viral vitamin B complex.
15. Conclusion and future perspective
Besides building and maintaining a stronger immune system, vitamin B can 
actually prevent or alleviate the symptoms of COVID-19 and / or treat infectious 
diseases with SARSCoV2. Inadequate nutritional conditions are much more sus-
ceptible to infections. Therefore, a balanced diet is needed to enhance immunity. 
Complementary or safe and cost-effective treatments are needed to reverse abnor-
mal activation of the immune system that can lead to cytokine storms and as an 
antiplatelet agent. An adequate intake of vitamins is essential for the normal func-
tioning of the body and the boosting of the immune system. B vitamins help control 
the immune response by decreasing pro-inflammatory cytokines and inflammatory 
conditions, minimising respiratory and gastrointestinal disease, preventing hyper-
coagulability, and possibly improving outcomes and shortening the hospital stay for 
COVID-19 patients.
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